Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Neoadjuvant Therapy Efficacy and Prognosis for Breast Cancer Based on Multimodal Data: A Multicenter Retrospective and Prospective Validation

NCT07671690 is registered in ClinicalTrials.gov with Yunnan Cancer Hospital as lead sponsor.

NCT NCT07671690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Neoadjuvant Therapy Efficacy and Prognosis for Breast Cancer Based on Multimodal Data: A Multicenter Retrospective and Prospective Validation
Lead sponsor
Yunnan Cancer Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 30, 2029
Enrollment
1,800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma